InvestSMART

AVITA Medical, Inc. (ASX: AVH) - Announcements

Current share price for AVH : $2.840 0.16 (5.33%)+

ASX company news and announcements for AVITA Medical, Inc. (AVH) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AVITA Medical, Inc. (AVH) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AVITA Medical, Inc. (AVH), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AVITA Medical, Inc. (AVH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$438 Notification regarding unquoted securities - AVH 9 Sep 2026 11:20AM $2.810 $2.830 risen by 0.71%
$438 Notification of cessation of securities - AVH 7 Sep 2026 3:37PM $3.020 $2.830 fallen by 6.29%
$438 AVITA to participate in US bank investor conferences 3 Sep 2026 8:19AM $2.800 $2.830 risen by 1.07%
$438 AVITA Investor Webinar Slides on PermeaDerm 19 Aug 2026 8:04AM $2.200 $2.830 risen by 28.64%
$438 AVITA announces positive PermeaDerm study results 19 Aug 2026 8:01AM $2.200 $2.830 risen by 28.64%
$438 Notification regarding unquoted securities - AVH 12 Aug 2026 11:22AM $2.240 $2.830 risen by 26.34%
$438 AVITA Medical Investor Presentation August 2026 10 Aug 2026 9:50AM $1.540 $2.830 risen by 83.77%
$438 AVITA Medical to Host Investor Webinar Briefing 10 Aug 2026 8:32AM $1.540 $2.830 risen by 83.77%
$438 AVITA to participate at Canaccord Genuity Growth Conference 10 Aug 2026 8:24AM $1.540 $2.830 risen by 83.77%
$438 Statement of CDIs on issue - AVH 7 Aug 2026 11:41AM $1.480 $2.830 risen by 91.22%
$438 AVITA 10-Q Quarterly Report for Q2 2026 7 Aug 2026 8:26AM $1.280 $2.830 risen by 121.09%
$438 Half Yearly Report 7 Aug 2026 8:26AM $1.280 $2.830 risen by 121.09%
$438 AVITA Q2 financial results earnings presentation 7 Aug 2026 8:26AM $1.280 $2.830 risen by 121.09%
$438 AVITA Medical announces Q2 2026 financial results 7 Aug 2026 8:26AM $1.280 $2.830 risen by 121.09%
$438 Notification of cessation of securities - AVH 6 Aug 2026 9:48AM $1.325 $2.830 risen by 113.58%
$438 AVITA to Announce Second Quarter 2026 Financial Results 15 Jul 2026 8:24AM $1.140 $2.830 risen by 148.25%
$438 Statement of CDIs on issue - AVH 14 Jul 2026 2:29PM $1.135 $2.830 risen by 149.34%
$438 Notification regarding unquoted securities - AVH 13 Jul 2026 8:24AM $1.235 $2.830 risen by 129.15%
$438 Notification regarding unquoted securities - AVH 13 Jul 2026 8:24AM $1.235 $2.830 risen by 129.15%
$438 Notification of cessation of securities - AVH 8 Jul 2026 4:36PM $1.400 $2.830 risen by 102.14%
$438 Notification of cessation of securities - AVH 3 Jul 2026 10:14AM $1.435 $2.830 risen by 97.21%
$438 AVITA Highlights first UK Clinical Experience with RECELL GO 19 Jun 2026 8:17AM $1.125 $2.830 risen by 151.56%
$438 Financial Report on Form 8-K Dated 5 June 2026 11 Jun 2026 10:26AM $1.145 $2.830 risen by 147.16%
$438 Change of Director's Interest Notice -SC JCC RM JSR MT CV JW 11 Jun 2026 10:24AM $1.145 $2.830 risen by 147.16%
$438 Notification regarding unquoted securities - AVH 11 Jun 2026 10:23AM $1.145 $2.830 risen by 147.16%

1 - 25 of 1367 results

Page 1 of 55

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.